VC fund manager AmorChem has launched AmorChem II, a $44.2m seed-stage life sciences fund backed by the government of Quebec.

Canada-based venture capital fund manager AmorChem Group launched a seed-stage life sciences fund on Wednesday with $44.2m of capital from limited partners including the Quebec government. Fonds de solidarité FTQ, the capital development organisation of Quebec, has also backed the fund, as has pharmaceutical firm Merck & Co. The fund will focus on investments in life…

The rest of this content is only accessible to Global Government Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.